Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
7.67 -0.16 / -2.04%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.67 0.00 / 0.00%
 
Volume: 463.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues76.9M14.0M7.9M44.4M
 
 
 
 
 
Cost of Goods Sold--499.0K624.0K855.0K
 
 
 
 
Depreciation And Amortization2.1M1.3M939.0K545.0K
 
 
 
 
 
 
Operating ExpensesGross Income--12.2M6.3M43.0M
 
 
 
 
General Expenses72.0M47.7M47.0M42.7M
 
 
 
 
 
Other Operating Expenses405.0K0.000.000.00
 
 
Research And Development53.8M33.0M34.1M27.7M
 
 
 
 
 
Total Operating Expenses74.5M49.5M48.6M44.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.5M-35.5M-40.7M296.0K
 
 
 
 
 
Extraordinary Credit0.000.00--7.3M
 
 
Extraordinary Charge0.000.00-2.3M-4.2M
 
 
 
Other Expenses7.9M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.4M-35.4M-42.9M3.4M
 
 
 
 
 
Income Taxes0.000.00-362.0K-989.0K
 
 
 
Net Income10.4M-35.4M-42.6M4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.4M34.8M55.8M68.2M
 
 
 
 
 
Shares To Calculate EPS Diluted33.5M34.8M55.8M68.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.31-$1.02-$0.76$0.06
 
 
 
 
 
EPS Diluted$0.31-$1.02-$0.76$0.06